Literature DB >> 30942083

CD44 epithelial isoform inversely associates with invasive characteristics of colorectal cancer.

Asieh Sadeghi1, Raheleh Roudi1, Alireza Mirzaei2, Ali Zare Mirzaei3, Zahra Madjd1,4, Maryam Abolhasani1,5.   

Abstract

Aim: There is no consensus regarding the clinical significance of CD44 and CD24 as cancer stem cell (CSC) marker in colorectal cancer (CRC). Methodology: A total of 494 CRC samples (2008-2017) were assessed for CD44 (epithelial isoform) and CD24 expression using tissue microarray.
Results: CD24 individually or in combination with CD44 was not associated with any of the clinicopathologic characteristics of the tumor. CD44 expression was inversely associated with pathological Tumor, Node, Metastasis (pTNM) lower stages (p = 0.038) and lymphatic invasion (p = 0.05).
Conclusion: In summary, the epithelial isoform of CD44 is inversely associated with invasive characteristics of CRC.

Entities:  

Keywords:  CD24; CD44; cancer stem cell; clinical significance of CD44 and CD24 in colorectal cancer; colorectal cancer; colorectal cancer stem cells; combined analysis; epithelial isoform; epithelial isoform of CD44; immunohistochemistry; invasion; tissue microarray

Mesh:

Substances:

Year:  2019        PMID: 30942083     DOI: 10.2217/bmm-2018-0337

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  18 in total

1.  Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Authors:  Raheleh Roudi; Mahboubeh Barodabi; Zahra Madjd; Giandomenico Roviello; Silvia Paola Corona; Mahshid Panahei
Journal:  Mol Cell Oncol       Date:  2020-07-14

2.  The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells.

Authors:  Chong Zhang; Huxia Gu; Dingrong Liu; Fuyun Tong; Huijie Wei; Dan Zhou; Jing Fang; Xiaolu Dai; Haibo Tian
Journal:  Mol Cell Biochem       Date:  2022-05-22       Impact factor: 3.396

Review 3.  Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.

Authors:  Mark Primeaux; Saiprasad Gowrikumar; Punita Dhawan
Journal:  Clin Exp Metastasis       Date:  2022-01-12       Impact factor: 5.150

4.  The Antitumor Activity of hAMSCs Secretome in HT-29 Colon Cancer Cells Through Downregulation of EGFR/c-Src/IRTKS Expression and p38/ERK1/2 Phosphorylation.

Authors:  Shamin Ebadi Zavieh; Fatemeh Safari
Journal:  Cell Biochem Biophys       Date:  2022-02-12       Impact factor: 2.989

5.  MiRNA505/NET1 Axis Acts as a CD8+ T-TIL Regulator in Non-Small Cell Lung Cancer.

Authors:  Pengyuan Zhu; Zhenchuan Liu; Haitao Huang; Chongjun Zhong; Yongxin Zhou
Journal:  Onco Targets Ther       Date:  2020-10-01       Impact factor: 4.147

6.  DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.

Authors:  Sepideh Razi; Asieh Sadeghi; Zeynab Asadi-Lari; Kevin J Tam; Elham Kalantari; Zahra Madjd
Journal:  Clin Exp Med       Date:  2020-09-23       Impact factor: 3.984

7.  Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer.

Authors:  Saeideh Gholamzadeh Khoei; Massoud Saidijam; Razieh Amini; Akram Jalali; Rezvan Najafi
Journal:  J Gastrointest Cancer       Date:  2021-02-13

8.  Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.

Authors:  Chukwuemeka Ihemelandu; Aisha Naeem; Erika Parasido; Deborah Berry; Krysta Chaldekas; Brent T Harris; Olga Rodriguez; Christopher Albanese
Journal:  Colorectal Cancer       Date:  2019-11-12

9.  MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma.

Authors:  Yangyang Xu; Zhenchuan Liu; Lixin Lv; Ping Li; Bing Xiu; Wenbin Qian; Aibin Liang
Journal:  J Exp Clin Cancer Res       Date:  2020-11-10

10.  RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls.

Authors:  Namjoo Kim; Jeong-An Gim; Beom Jae Lee; Byung Il Choi; Seung Bin Park; Hee Sook Yoon; Sang Hee Kang; Seung Han Kim; Moon Kyung Joo; Jong-Jae Park; Chungyeul Kim; Han-Kyeom Kim
Journal:  Funct Integr Genomics       Date:  2021-07-17       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.